FIELD: medicine, oncology.
SUBSTANCE: one should carry out immunohistochemical and morphological tumoral study. At values of antigen KI-67 expression level being below 10%, mutated gene-suppressor P53 being below 10% and mitotic activity in the tumor being below 10 mitoses per 10 vision fields one should predict favorable prognosis of the disease. At values of Ki-67 being above 10%, P53 being above 10% and mitotic activity in tumor being above 10 mitoses per 10 vision fields one should predict unfavorable prognosis of the disease in question. The innovation enables to obtain quantitative objectivity of the results achieved.
EFFECT: higher accuracy of prediction.
1 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETECTING EFFICIENCY OF ANTI-TUMOR THERAPY OF SKIN MELANOMAS | 2004 |
|
RU2280483C2 |
| METHOD FOR ESTIMATING SKIN MELANOMA NEOADJUVANT TREATMENT EFFECTIVENESS | 2006 |
|
RU2322194C1 |
| METHOD FOR PREDICTION OF METASTASES IN PATIENTS WITH STOMACH CANCER | 2010 |
|
RU2445632C1 |
| METHOD PREDICTING CLINICAL COURSE OF UVEA MELANOMA BASED ON APOPTHOSIS MARKER p53 | 2002 |
|
RU2208789C1 |
| METHOD FOR DETERMINING AUTOHEMOCHEMOTHERAPY EFFECTIVENESS IN TREATING THE CASES OF CARCINOMA AFFECTING RECTOSIGMOID PORTION OF THE RECTUM AND SIGMOID COLON AND AUTOHEMOCHEMOTHERAPY COMBINED WITH ULTRAHIGH FREQUENCY HYPERTHERMIA IN TREATING THE CASES OF RECTAL CARCINOMA | 2001 |
|
RU2219553C2 |
| CELL LINE CROV CEL OF HUMAN MUCINOUS OVARIAN CARCINOMA INTENDED FOR DEVELOPMENT OF TREATING WITH TARGET PREPARATIONS | 2016 |
|
RU2608960C1 |
| METHOD OF PREDICTION OF CLINICAL COURSE OF UVEA MELANOMA BASED ON APOPTHOSIS MARKER Bax | 2002 |
|
RU2208790C1 |
| METHOD FOR PREDICTING UVEAL MELANOMA METASTASIS FORMATION ON THE BASIS OF BAX AND KI-67 MARKERS | 2003 |
|
RU2240560C1 |
| METHOD OF EVALUATING EFFICIENCY OF INTRAMURAL AUTOPLASMOCHEMICAL THERAPY OF URINE BLADDER CANCER | 2009 |
|
RU2398517C1 |
| METHOD FOR REMISSION DURATION PREDICTION IN PATIENTS WITH VULVA CANCER | 2016 |
|
RU2624508C1 |
